Tobacco Documents Online

Re: AMA-ERF Abstracts

Abstract

States that lthough the comments in the introductory parts of the ERF report are not supportable by the work done under the AMA-ERF grant, critiquing them, apart from being questionable if done by someone from the tobacco industry, requires much work, and is not worth the effort.

User-Contributed Notes

1. funding tobacco industry internal activity

Fields

Date Loaded

08 Jan 2003

Type

Letter

Named Person

Hockett, Robert Casad, Ph.D. (CTR Scientific Director)

Scientific Director of the Council for Tobacco Research from 1972-1974 (WSJ 2/11/93; Allman complaint). Bio-Research Institute BRI conducted a study for the CTR. When Syrian hamsters were exposed to smoke twice a day for 59 to 80 weeks, 40% of those of a cancer-susceptible strain and 4% of a resistant strain developed malignant tumors (WSJ 2/11/93). Before publishing the study in 1974, BRI's founder, Frederic Homberger, sent a manuscript to Robert Hockett, then scientific director of the CTR. Dr. Homberger says he had to do so because halfway through his study, the CTR had changed it from a grant to a contract so they could control publication. They were quite open about that (WSJ 2/11/94. Soon thereafter, Hockett and CTR lawyer Edwin Jacob went to Dr. Homburger's summer house in Maine. Hockett and Jacob did not want BRI to call anything cancer, they wanted it to be "pseudo-epitheliomatous hyperplasis," a euphemism for lesions preceding cancer (WSJ 2/11/93). Dr. Homberger said no, this is not right, it is cancer. Jacob told Dr. Homberger that BRI would never get a penny more if the paper was published without the changes. At the last minute, Dr. Homberger changed the final proofs to read "microinvasive" cancer, a microscopic malignancy. Nevertheless, BRI was never funded by the CTR again (WSJ 2/11/96) Hochett made a statement, as scientific director of the CTR circa February 1972 that neither tobacco and health research in general, nor that of the Council for Tobacco Research has established that tobacco use or cigarette smoking in particular is a major health hazard (Allman complaint, pp. 41-42). Robert C. Hockett was Scientific Director, Vice President and Research Director of CTR. See Bio-Research Institute, TTLA Almanac - Names. (N.M.'s CTR Who's Who)

Gardner, William Ullman, Ph.D. (CTR Scientific Advisory Board grant reviewer)

Dr. Gardner worked for Counsel for Tobacco Research -- U.S.A., Inc. He was a member of CTR's committee which reviewed grant applications in 1974. (UCSF000134) Gardner served on the Scientific Advisory Board for CTR and was a CTR Scientific Director. (N.M.'s CTR Who's Who) (PMI's Introduction to Privilege Log and Glossary of Names, Estate of Burl Butler v. PMI, et al, April 19, 1996). See Gardiner, Bill, TTLA Almanac - Names.

Edens, Joseph E. (BW; CTR Director)

Joseph E. Edens was an employee of Brown & Williamson Tobacco Corporation and served as Director and on the Executive Committee for the Council for Tobacco Research

Named Organization

American Medical Association (physicians group)

Professional trade group representing American physicians.

Surgeon General of the United States Public Health Service (U.S. Federal government public health advocate)

The U.S. Surgeon General's office has found since 1964 that tobacco use causes disease in humans.

Author (Organization)

Council for Tobacco Research - USA (CTR) (Formerly Tobacco Industry Research Committee (TIRC))

Originally organized as the Tobacco Industry Research Committe(TIRC) in 1954, and renamed Council for Tobacco Research - USA, Inc. (CTR) in 1964.

Author

@yeaman_addison (?)

Recipient (Organization)

Brown & Williamson Industries (Cigarette manufacturer)

Brown & Williamson Tobacco Corporation became Brown & Brown & Williamson Industries in 1974 (L. White, Merchants 1988). B&W brands include: Cool, Viceroy, Raleigh, Barclay, Belaire, Copre, Fact, Richland and GPC, 1976.

Recipient

Pepples, Ernest, J.D. (BW General Counsel and Sr. VP)